Holen Sie sich die Stockscreener-App
26.33
3.27%
-0.89
Handel nachbörslich:
26.33
Finanzdaten der Centessa Pharmaceuticals Plc Adr-Aktie (CNTA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | 15.00 | - | - |
| Operating Expenses |
1.58%
53.79
|
54.65 | 45.78 | - | - |
| Benefits Costs and Expenses |
10.41%
54.73
|
49.56 | 39.74 | - | - |
| Costs And Expenses |
10.41%
54.73
|
49.56 | 39.74 | - | - |
| Operating Income/Loss |
1.58%
-53.79
|
-54.65 | -30.78 | -74.58 | -46.41 |
| Income/Loss From Continuing Operations Before Tax |
10.41%
-54.73
|
-49.56 | -24.74 | -110.28 | -41.96 |
| Income Tax Expense/Benefit, Deferred |
75.15%
0.255
|
1.026 | 0.995 | 0.398 | 1.254 |
| Income Tax Expense/Benefit |
78.66%
0.166
|
0.778 | 1.397 | 1.05 | 0.608 |
| Income/Loss From Continuing Operations After Tax |
9.03%
-54.89
|
-50.34 | -26.14 | -111.33 | -42.57 |
Net Income/Loss
|
9.03%
-54.89
|
-50.34 | -26.14 | -111.33 | -42.57 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.36%
134.16
|
133.68 | 133.03 | 5.9017 | 116.25 |
| Diluted Average Shares |
0.36%
134.16
|
133.68 | 133.03 | 5.9017 | 116.25 |
| Basic Earnings Per Share |
7.89%
-0.41
|
-0.38 | -0.20 | -0.91 | -0.37 |
| Diluted Earnings Per Share |
7.89%
-0.41
|
-0.38 | -0.20 | -0.91 | -0.37 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):